Stock Market & Financial News

Loading...
Palantir Stock: The Setup For The Next Major Rally

Palantir Stock: The Setup For The Next Major Rally

Palantir Technologies has undergone several explosive rallies, with key years such as 2020 and 2024 witnessing over 50% gains in less than two months. Moreover, the stock has risen by more than 30% multiple times during previous upswings, particularly in 2023 and 2024, providing considerable rewards to shareholders.

Forbes | 2 hours ago

Why BDC Dividend Cuts Matter Less Than You Think

System-wide BDC dividend cuts are highly likely as base dividend coverage averages 99% and growth is constrained. As a result, many BDC investors have decided to sit on the sidelines until the expected dividend cuts materialize. The idea is that a cut will lead to a negative share price reaction and thus provide a better opportunity to buy at a bargain price.

Seekingalpha | 2 hours ago

Home Depot beats Wall Street's projections for the fourth quarter even as shoppers remain cautious

Home Depot's fourth-quarter performance was muted by ongoing caution from American consumers in a weak housing market, but the home improvement retailer topped Wall Street expectations.The Atlanta company earned $2.57 billion, or $2.58 per share, for the three months ended Feb. 1. Stripping out one-time charges or benefits, earnings were $2.72 per share, topping analyst projections for per-share earnings of $2.53, according to FactSet.A year earlier it earned $3 billion, or $3.02 per share.An extra week in fiscal 2024 added approximately 30 cents per share to the year-ago quarter.Home Depot's stock rose more than 3% before the market opened on Tuesday.Revenue totaled $38.2 billion, down from $39.7 billion a year earlier.

Fastcompany | 2 hours ago

Factors Are Driving Global Yields Higher in 2026: Active Investing Can Help

Uncertainty is the name of the game right now for investors, but with uncertainty comes opportunity. The myriad of challenges impacting markets right now may also be driving global yields higher.

Etftrends | 2 hours ago
PPL Gains 2.1% in Three Months: Worth Including in Your Portfolio?

PPL Gains 2.1% in Three Months: Worth Including in Your Portfolio?

PPL gains 2.1% in three months as it boosts capex to $23B, taps data center demand and targets steady dividend growth.

Zacks | 2 hours ago
Disruptive Theme of the Week: Some Surprise Winners YTD

Disruptive Theme of the Week: Some Surprise Winners YTD

Market predictions are not easy to make and looking at the YTD winners, there are some head-scratchers.  Let's take a closer look and make some sense out of the recent performance winners: wet and dry shipping; South Korea; and oil services ETFs.

Etftrends | 2 hours ago
Public Service Enterprise to Release Q4 Earnings: What's in Store?

Public Service Enterprise to Release Q4 Earnings: What's in Store?

PEG heads into Q4 with data center-driven demand and rate gains set to lift revenues, though higher costs may pressure earnings.

Zacks | 2 hours ago
Conduent data breach grows, affecting at least 25M people

Conduent data breach grows, affecting at least 25M people

The spillover from a ransomware attack on one of the largest government contractors in the United States keeps getting bigger: more than 25 million people have now had personal data stolen in the hack.

Techcrunch | 2 hours ago
Bonesupport Holding AB (publ) (BOEUF) Q4 2025 Earnings Call Transcript

Bonesupport Holding AB (publ) (BOEUF) Q4 2025 Earnings Call Transcript

Bonesupport Holding AB (publ) (BOEUF) Q4 2025 Earnings Call Transcript

Seekingalpha | 2 hours ago
You Could Have Captured Gold's 73% Surge For Only 0.18%

You Could Have Captured Gold's 73% Surge For Only 0.18%

Gold has returned 73% over the past year and 18% year-to-date through February 20, 2026, outpacing most traditional asset classes.

247wallst | 2 hours ago

Kratos Defense Q4 Earnings and Revenues Surpass Estimates

KTOS' fourth-quarter earnings jump 38.5%, and revenues surge 21.9%, beating estimates as backlog hits $1.21 billion.

Zacks | 2 hours ago

CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?

CorMedix and Theravance take sharply different routes to small-cap biotech growth - one fueled by sales traction, the other by pipeline promise.

Zacks | 2 hours ago

Is Cybersecurity as a Service Becoming Allot's Core Growth Engine?

ALLT's SECaaS ARR jumps 60% in Q3 2025, lifting recurring revenues to 63% and nearing 30% of sales as new telecom deals fuel growth.

Zacks | 3 hours ago

Can TSM Sustain 60%+ Gross Margin Amid Overseas Fab Expansion?

Taiwan Semiconductor targets 63%-65% gross margin in Q1 despite a 2%-4% hit from overseas fabs as AI and advanced node demand fuels global expansion.

Zacks | 3 hours ago

Sempra Energy Set to Report Q4 Earnings: What's in the Offing?

SRE's Q4 results may benefit from new interim rates and steady customer growth, but mild weather and higher costs are likely to have pressured the bottom line.

Zacks | 3 hours ago

AI Scare Back in the Market: ETFs That Stayed Steady

AI fears rattled markets as IBM sank and tech slid, but ETFs like OIH, BWET, IDNA and HDGE stayed resilient, gaining even as major indexes fell.

Zacks | 3 hours ago

Intel's Fight For Survival: Can It Outrun The Giants?

Intel's shares have seen a positive performance over the last year, increasing by 75%. Nevertheless, how does it measure up against competitors that are rapidly expanding within the AI and semiconductor sectors?

Forbes | 3 hours ago

Hewlett Packard Enterprise: Network And Infrastructure Integration Set To Deliver Growth

Hewlett Packard Enterprise is upgraded to Strong Buy with a $29.29/share target, driven by AI rack-scale infrastructure growth and Juniper integration. HPE is positioned for strong eFY26 growth, leveraging AMD and Nvidia partnerships, despite memory chip cost headwinds and cyclical server demand dynamics. HPE may face some headwinds resulting from rising memory chip prices, intending to increasing server prices to offset the costs.

Seekingalpha | 3 hours ago

Novo Nordisk: Investors Focusing On CagriSema Results Are Missing The Big Picture

Novo Nordisk A/S remains a buy despite CagriSema's failure to match tirzepatide in head-to-head trials, as the market overreacts to short-term setbacks. NVO's oral Wegovy pill is poised to drive future growth, offering superior convenience, strong efficacy, and rapid uptake, especially outside the US when it gains approval. Current negative sentiment and market share losses are offset by robust international growth, resilient fundamentals, and a compelling valuation at 13x forward earnings.

Seekingalpha | 3 hours ago

Warner Bros Discovery is now running a merger auction with a March 20 deadline and Hollywood's future at stake

Netflix has a signed deal and the cash to defend it. Paramount has a higher bid and a political edge.

Proactiveinvestors | 3 hours ago

SMR Targets 72 Modules With ENTRA1: Is Deployment on Track for 2030?

NuScale Power's 6GW ENTRA1 plan targets 72 modules by 2030, but no binding PPAs and execution risks can test the ambitious timeline.

Zacks | 3 hours ago

Micron Stock: Is The AI Memory Boom Just Beginning?

Micron Technology (MU) stock is currently in a fascinating position. It exhibits robust momentum, and investing in it means supporting a company that possesses strong margins, healthy cash flow, a low-debt capital structure, and favorable market conditions.

Forbes | 3 hours ago

Oklo Is Turning Waste Into Watts

I'm initiating Oklo Inc. with a Buy and see that the 30% pullback gives a favorable risk-reward entry at current levels. OKLO's Utility-as-a-Service model, anchored by long-term PPAs like Meta's 1.2 GW deal, offers high-margin, recurring revenue and multi-billion-dollar backlog. Vertical integration, including fuel recycling, fabrication, and advanced fast-fission tech, positions OKLO as a primary beneficiary of the U.S. HALEU and clean energy push.

Seekingalpha | 3 hours ago

Argentina Lithium revises LIFE offering to raise up to C$4.3M

Argentina Lithium & Energy Corp (TSX-V:LIT, OTCQX:LILIF) said it has amended the terms of its previously announced “best efforts” marketed offering under the listed issuer financing exemption (LIFE), with plans to raise up to C$4.3 million in gross proceeds. The Vancouver-based company has entered into an agreement with Red Cloud Securities Inc., which is acting as sole agent and bookrunner for the offering.

Proactiveinvestors | 3 hours ago

Netskope: This Dip Is Irrational, And Should Be Bought Aggressively

Shares of Netskope have tumbled on the broad cybersecurity selloff to a

Seekingalpha | 3 hours ago

BYD Shows It Is King Of The EV Market

The world economy is generally divided into three regions. One is China.

247wallst | 3 hours ago

LRCX vs. ASML: Which Semiconductor Equipment Giant Is the Better Buy?

Lam Research edges ahead of ASML Holding with stronger growth forecasts, solid AI-driven demand and a more attractive valuation in the chip equipment race.

Zacks | 3 hours ago

Tianrong Internet Products and Services Inc. (OTC: TIPS) Provides Post-Launch Update on DEPIN Token and Outlines Phase II Expansion Strategy for Depinfer

Company Advances Decentralized GPU Compute Network with Staking, Governance, and AI Marketplace Enhancements Planned for Phase II Completion by March 2026 Mountainhome, PA, February 24, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Tianrong Internet Products and Services Inc.

Prismmediawire | 3 hours ago

Nvidia to pay dividends on March 27; Here's how much 100 NVDA shares will earn

Nvidia (NASDAQ: NVDA) stock is back in the green in 2026 and the AI chipmaker is expected to pay its first dividend of the year later next month.

Finbold | 3 hours ago

Hims & Hers Health After The GLP-1 Collapse

Hims & Hers Health's revenue grew 59% to $2.35B in 2025, while adjusted EBITDA surged nearly 80% to $318M. Operating cash flow reached $300M, with $929M in liquidity, reinforcing balance sheet strength. GLP-1 drove higher revenue per order, but most profitability remains in non-weight-loss categories.

Seekingalpha | 3 hours ago
Load More
Loading...